Meta-analysis of 15 longitudinal studies (8 trials; >1.5 million patients): GLP-1 RA use was associated with higher NAION risk (OR 1.70; 95% CI 1.23-2.36; absolute risk 0.09%, NNH ~2,700) but not with overall ocular events (OR 0.95).
Meta-analysisn = 15 studies
Nogueira et al. Association Between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy: A Meta-analysis